Thomas Englese - 08 Sep 2022 Form 4 Insider Report for AZIYO BIOLOGICS, INC. (ELUT)

Role: CHIEF COMMERCIAL OFFICER
Signature: /s/ Jeffrey Hamet, Attorney-in-Fact for Thomas Englese
Issuer symbol: ELUT
Transactions as of: 08 Sep 2022
Net transactions value: -$34,514
Form type: 4
Filing time: 12 Sep 2022, 17:05:46 UTC
Previous filing: 10 Mar 2022
Next filing: 09 Mar 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ELUT	Class A Common Stock	Options Exercise		+15,390	+233%		21,997	08 Sep 2022	Direct	F1
transaction	ELUT	Class A Common Stock	Tax liability	$34,514	-4,728	-21%	$7.30^*	17,269	08 Sep 2022	Direct	F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ELUT	Restricted Stock Units	Options Exercise	$0	-15,390	-100%	$0.000000^*	0	08 Sep 2022	Class A Common Stock	15,390		Direct	F1, F3

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class A Common Stock. Transaction represents shares of the Issuer's Class A Common Stock received from the vesting of restricted stock units.
F2	Shares withheld by the Issuer to satisfy tax withholding requirements on vesting of restricted stock units.
F3	The restricted stock units granted on March 8, 2022 vested in full on September 8, 2022.